本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

101.00
+1.591.60%
成交量:26.38万
成交额:2,666.19万
市值:67.40亿
市盈率:-32.52
高:101.98
开:99.85
低:99.57
收:99.41
52周最高:116.00
52周最低:45.91
股本:6,673.61万
流通股本:5,341.51万
量比:0.70
换手率:0.49%
股息:- -
股息率:- -
每股收益(TTM):-3.1057
每股收益(LYR):-4.3376
净资产收益率:-85.79%
总资产收益率:-26.74%
市净率:45.29
市盈率(LYR):-23.28

数据加载中...

2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities